Adverse drug reaction: pomalidomide-induced liver injury

Lancet. 2014 Jun 21;383(9935):2125-6. doi: 10.1016/S0140-6736(14)61030-8.

Authors

Rajwanth R Veluswamy¹, Stephen C Ward², Kendra Yum³, Rebecca B Abramovitz³, Luis M Isola⁴, Sundar Jagannath⁴, Samir Parekh⁴

Affiliations

¹ Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: rajwanth.veluswamy@mountsinai.org.
² Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
³ Department of Pharmacy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁴ Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

PMID: 24953475
DOI: 10.1016/S0140-6736(14)61030-8

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Chemical and Drug Induced Liver Injury / etiology*
Humans
Male
Middle Aged
Multiple Myeloma / therapy
Stem Cell Transplantation
Thalidomide / adverse effects
Thalidomide / analogs & derivatives*

Substances

Thalidomide
pomalidomide